Psyence Biomedical Ltd. - Ordinary Shares
Psyence Biomedical Ltd. - Ordinary Shares
Share · CA74449F1009 · PBM (XNAS)
Overview Financial Indicators
4,80 USD
-3,42 % -0,17 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
12.06.2025 23:36

Current Prices from Psyence Biomedical Ltd. - Ordinary Shares

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
PBM
USD
12.06.2025 23:36
4,80 USD
4,97 USD
-3,42 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -12,73 % 29,20 % -89,98 % -95,80 % -100,00 % -100,00 %

Firmenprofil zu Psyence Biomedical Ltd. - Ordinary Shares Aktie

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.

Unternehmensdaten

Name Psyence Biomedical Ltd. - Ordinary Shares
Firma Psyence Biomedical Ltd.
Symbol PBM
Website https://www.psyencebiomed.com
Heimatbörse XNAS NASDAQ
ISIN CA74449F1009
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Neil Maresky M.D.
Land Kanada
Währung USD
Mitarbeiter 0,0 T
Adresse 121 Richmond Street West, M5H2K1 Toronto
IPO Datum 2021-12-10

Aktien-Splits

Datum Split
05.05.2025 1:8
05.05.2025 1:7
26.11.2024 1:75
25.11.2024 1:75

Ticker Symbole

Name Symbol
NASDAQ PBM

Weitere Aktien

Investoren die Psyence Biomedical Ltd. - Ordinary Shares die halten, haben auch folgende Aktien im Depot:
AMUNDI FUNDS JAPAN EQUITY VALUE - I2 EUR HGD (C)
AMUNDI FUNDS JAPAN EQUITY VALUE - I2 EUR HGD (C) ETF
PROPERTY FRANCHISE GROUP PLC (THE) - ORD 1P
PROPERTY FRANCHISE GROUP PLC (THE) - ORD 1P Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025